Precedential Federal Circuit Opinions:
In Re NITRO FLUIDS L.L.C. [ORDER] (2020-0142, 10/28/28) (REYNA, WALLACH, and CHEN) -
Reyna, J. The Court considered a petition for a writ of mandamus seeking transfer from the...more
11/11/2020
/ Abbreviated New Drug Application (ANDA) ,
Abuse of Discretion ,
Analogous Art ,
Apple ,
Chevron ,
Claim Construction ,
Federal Rules of Civil Procedure ,
First-to-File ,
Hatch-Waxman ,
Mandamus Petitions ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Precedential Opinion ,
Transfer of Venue ,
Venue ,
Writ of Mandamus
Precedential Federal Circuit Opinions -
ANTENNASYS, INC. v. AQYR TECHNOLOGIES, INC. [OPINION] (O’Malley, Bryson, Reyna) -
O’Malley, J. Remanding to district court to address threshold issues of whether case should be...more
We surveyed inter partes review proceedings instituted in the year following the U.S. Supreme Court's 2018 decision in SAS Institute Inc. v. Iancu, and identified five takeaways regarding the Patent Trial and Appeal Board's...more
Six years after the America Invents Act created inter partes review proceedings, patent disputes increasingly involve parallel litigation, with at least one inter partes review proceeding in tandem with district court...more
In Teva Pharmaceuticals USA Inc. v. Sandoz Inc., the U.S. Supreme Court held that clear error review applies to factual determinations underlying district court claim constructions. There has been much discussion about the...more
7/13/2016
/ Claim Construction ,
Clear Error Standard ,
Collateral Estoppel ,
Final Judgment ,
Issue Preclusion ,
Markman Hearing ,
Patent Litigation ,
Patents ,
Settlement ,
Summary Judgment ,
Teva v Sandoz
The Federal Circuit sitting en banc recently held in Tam that Section 2(a) of the Lanham Act, which prohibits the U.S. Patent and Trademark Office from registering trademarks that “may disparage” persons, institutions, or...more